Literature DB >> 34274350

GluA1-homomeric AMPA receptor in synaptic plasticity and neurological diseases.

Yuan Ge1, Yu Tian Wang2.   

Abstract

Synaptic transmission is one of the fundamental processes that all brain functions are based on. Changes in the strength of synaptic transmission among neurons are crucial for information processing in the central nervous system. The α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of ionotropic glutamate receptors (AMPARs) mediate the majority of the fast excitatory synaptic transmission in the mammalian brain. Rapid trafficking of AMPARs in and out of the postsynaptic membrane is proposed to be a major mechanism for synaptic plasticity, and learning and memory. Defects in the regulated AMPAR trafficking have been shown to be involved in the pathogenesis of certain psychiatric and neurodegenerative diseases. Studies accumulated in the past 30 years have provided a detailed molecular insight on how the trafficking of AMPARs is modulated in a subunit-specific manner. In particular, emerging evidence supports that the regulated expression and trafficking of Ca2+-permeable, GluA1-homomeric subtype of AMPARs mediates diverse types of synaptic plasticity, thereby playing critical roles in brain function and dysfunction. In this review, we will discuss the current knowledge of AMPAR subunit-specific trafficking, with a particular emphasis on the involvement of GluA1-homomeric receptor trafficking in synaptic plasticity and brain disorders. This article is part of the special Issue on 'Glutamate Receptors - AMPA receptors'.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPA receptor; Ca(2+)-permeable AMPA receptor; Drug addiction; GluA1-homomeric AMPA receptor; Ischemia; Long-term depression; Long-term potentiation; Synaptic plasticity; p97

Mesh:

Substances:

Year:  2021        PMID: 34274350     DOI: 10.1016/j.neuropharm.2021.108708

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Structural Investigation of the Interaction Mechanism between Chlorogenic Acid and AMPA Receptor via In Silico Approaches.

Authors:  Wei Zhu; Fengming Wu; Jindie Hu; Wenjing Wang; Jifeng Zhang; Guoqing Guo
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

2.  Mutually Dependent Clustering of SynDIG4/PRRT1 and AMPA Receptor Subunits GluA1 and GluA2 in Heterologous Cells and Primary Neurons.

Authors:  Kristopher E Plambeck; Chun-Wei He; Hector H Navarro; Elva Díaz
Journal:  Front Mol Neurosci       Date:  2022-04-08       Impact factor: 6.261

Review 3.  Neuroplastin in Neuropsychiatric Diseases.

Authors:  Xiao Lin; Yi Liang; Rodrigo Herrera-Molina; Dirk Montag
Journal:  Genes (Basel)       Date:  2021-09-26       Impact factor: 4.096

Review 4.  AMPA Receptor Function in Hypothalamic Synapses.

Authors:  Maria Royo; Beatriz Aznar Escolano; M Pilar Madrigal; Sandra Jurado
Journal:  Front Synaptic Neurosci       Date:  2022-01-31

5.  Identification and functional evaluation of GRIA1 missense and truncation variants in individuals with ID: An emerging neurodevelopmental syndrome.

Authors:  Vardha Ismail; Linda G Zachariassen; Annie Godwin; Mane Sahakian; Sian Ellard; Karen L Stals; Emma Baple; Kate Tatton Brown; Nicola Foulds; Gabrielle Wheway; Matthew O Parker; Signe M Lyngby; Miriam G Pedersen; Julie Desir; Allan Bayat; Maria Musgaard; Matthew Guille; Anders S Kristensen; Diana Baralle
Journal:  Am J Hum Genet       Date:  2022-06-07       Impact factor: 11.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.